Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model
Jonathan Brouillette(Inserm), Luc Buée(Inserm)
Cited by 171
Related Papers
Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits
|American Journal Of Pathology|2006|383
Tau Phosphorylation and Sevoflurane Anesthesia
|Anesthesiology|2012|212
Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers
|Scientific Reports|2020|50
Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats
|Alzheimer s Research & Therapy|2023|13